Literature DB >> 23733970

Active cardiac sarcoidosis: first clinical experience of simultaneous positron emission tomography--magnetic resonance imaging for the diagnosis of cardiac disease.

James A White1, Martin Rajchl, John Butler, R Terry Thompson, Frank S Prato, Gerald Wisenberg.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 23733970     DOI： 10.1161/CIRCULATIONAHA.112.001217

Source DB:  PubMed          Journal:  Circulation        ISSN： 0009-7322            Impact factor:   29.690


× No keyword cloud information.
  32 in total

Review 1.  PET/MRI: current state of the art and future potential for cardiovascular applications.

Authors:  Nebiyu Adenaw; Michael Salerno
Journal:  J Nucl Cardiol       Date:  2013-12       Impact factor: 5.952

Review 2.  Cardiac Applications of PET-MR.

Authors:  Peter J Bergquist; Michael S Chung; Anja Jones; Mark A Ahlman; Charles S White; Jean Jeudy
Journal:  Curr Cardiol Rep       Date:  2017-05       Impact factor: 2.931

3.  Multimodality imaging in the diagnosis and management of cardiac sarcoidosis.

Authors:  Shant J Manoushagian; Vladimir Lakhter; Pravin V Patil
Journal:  J Nucl Cardiol       Date:  2016-11-11       Impact factor: 5.952

4.  Evolving Use of Molecular Imaging in Research and in Practice.

Authors:  Ahmed Tawakol; Sebastian Unizony; Michael T Osborne; Elena Massarotti; Jon T Giles
Journal:  Arthritis Rheumatol       Date:  2019-08       Impact factor: 10.995

5.  Evaluation of a low-carbohydrate diet-based preparation protocol without fasting for cardiac PET/MR imaging.

Authors:  Felix Nensa; E Tezgah; K Schweins; J Goebel; P Heusch; K Nassenstein; T Schlosser; T D Poeppel
Journal:  J Nucl Cardiol       Date:  2016-03-18       Impact factor: 5.952

Review 6.  Disease-specific cardiovascular positron emission tomography/magnetic resonance imaging: a brief review of the current literature.

Authors:  Jeffrey M C Lau; Jie Zheng
Journal:  Quant Imaging Med Surg       Date:  2016-06

7.  Feasibility of FDG-PET in myocarditis: Comparison to CMR using integrated PET/MRI.

Authors:  Felix Nensa; Julia Kloth; Ercan Tezgah; Thorsten D Poeppel; Philipp Heusch; Juliane Goebel; Kai Nassenstein; Thomas Schlosser
Journal:  J Nucl Cardiol       Date:  2016-09-08       Impact factor: 5.952

Review 8.  Clinical use of cardiac PET/MRI: current state-of-the-art and potential future applications.

Authors:  Patrick Krumm; Stefanie Mangold; Sergios Gatidis; Konstantin Nikolaou; Felix Nensa; Fabian Bamberg; Christian la Fougère
Journal:  Jpn J Radiol       Date:  2018-03-10       Impact factor: 2.374

9.  Comparison of (18)F-fluorodeoxyglucose positron emission tomography (FDG PET) and cardiac magnetic resonance (CMR) in corticosteroid-naive patients with conduction system disease due to cardiac sarcoidosis.

Authors:  Hiroshi Ohira; David H Birnie; Elena Pena; Jordan Bernick; Brian Mc Ardle; Eugene Leung; George A Wells; Keiichiro Yoshinaga; Ichizo Tsujino; Takahiro Sato; Osamu Manabe; Noriko Oyama-Manabe; Masaharu Nishimura; Nagara Tamaki; Alexander Dick; Carole Dennie; Ran Klein; Jennifer Renaud; Robert A deKemp; Terrence D Ruddy; Benjamin J W Chow; Ross Davies; Renee Hessian; Peter Liu; Rob S B Beanlands; Pablo B Nery
Journal:  Eur J Nucl Med Mol Imaging       Date:  2015-09-11       Impact factor: 9.236

10.  Image fusion between 18F-FDG PET and MRI in cardiac sarcoidosis: A case series.

Authors:  Shahin Zandieh; Reinhard Bernt; Siroos Mirzaei; Joerg Haller; Klaus Hergan
Journal:  J Nucl Cardiol       Date:  2016-09-07       Impact factor: 5.952
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.